Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)
A Prospective, Randomized, Multicenter Study To Compare The Safety And Effectiveness Of The OMNI® Surgical System And The iStent Inject In Pseudophakic Eyes With Open Angle Glaucoma. The TRIDENT European Trial
Sponsor: Sight Sciences, Inc.
Terminated
Business Decision
Other terminated trials from Sight Sciences, Inc.
- Primary Open Angle Glaucoma · Phase PHASE4 · Jan 2025
- Glaucoma, Open-Angle · Phase NA · Mar 2021
- Glaucoma, Open-Angle · Phase NA · Jan 2021
- Open-Angle Glaucoma · Phase NA · Jan 2019
- Dry Eye Syndromes · Phase NA · Dec 2018
More terminations from Sight Sciences, Inc.
Other Glaucoma, Open-Angle trials with similar outcome
A NA clinical study on Glaucoma, Open-Angle, this trial is terminated or withdrawn. The trial is conducted by Sight Sciences, Inc. and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Nov 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Nov 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Apr 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jan 2021 — Apr 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sight Sciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .